This week, Representatives Dana Rohrabacher, Earl Blumenauer, and allies in the House of Representatives have again offered the Rohrabacher-Blumenauer amendment to protect lawful state medical marijuana programs from the federal government. Specifically, it would limit the Justice Department from taking action against state-sanctioned medical cannabis producers, retailers, or consumers.
Although the amendment was reauthorized by Congress in May, US Attorney General Jeff Sessions has been aggressively lobbying leadership to ignore the provisions. At the time, President Trump issued a signing statement objecting to the Rohrbacher-Blumenauer provision.
Nonetheless, support for the Rohrbacher-Blumenauer protection amendment has only grown in recent years. House members initially passed the amendment as a budgetary rider in 2014 by a vote of 219 to 189. By the following year, 242 House members voted in support of the language.
To date, the language has not been included in the base appropriations bill and in every case of its passage, it has required being added as a separate rider by a vote on the floor of the House.
Now, Rules Committee Chairman Pete Sessions may deny the democratic process and not allow the amendment to be considered for a full vote of the House.
You can send an email to your Representative now to urge their support and co-sponsorship of the amendment by clicking HERE.
In July, Senator Patrick Leahy (D-VT) successfully offered and passed the Rohrabacher-Blumenauer amendment in the Senate Appropriations Committee, meaning that the language will be considered in a conference committee should the House be denied the opportunity to express it’s support for the 30 states which have legalized medical marijuana and 16 states that have authorized CBD oil access.
Finally, join us for our 2017 National Conference and Lobby Day to speak with your elected officials and their staffers in person, September 10th – 12th. Click here to find out more and get your tickets.
